Indoco Remedies Limited

Indoco Remedies Limited

Indoco Remedies Limited has scheduled an earnings conference call for Q1 FY2026-2027 on July 28, 2026, to discuss unaudited financial results for the quarter ended June 30, 2026.

Indoco Remedies Limited

Indoco Remedies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026.

Indoco Remedies Limited

Indoco Remedies Limited has informed the Exchange regarding a press release dated Jun 26, 2026, titled "Indoco Remedies Goa Plant successfully clears Malta Medicines Authority audit". The company's manufacturing facility for solid oral dosage form (Plant I) located at Goa has received EU GMP certification from the Malta Medicines Authority confirming that it complies with the Good Manufacturing Practice requirements as referred in the EC Directive.